Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Microbial Transformation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1212403C reveals a microbial method for high-purity (S)-phenylglycol. Discover cost-effective biocatalysis for reliable chiral intermediate supply chains.
Patent CN104357526A reveals green DES-based cholestenone production. Enhances solubility and safety for pharmaceutical intermediate supply chains.
Novel Gibberella intermedia method for steroid intermediates. High yield conversion reduces manufacturing costs and ensures supply chain reliability for pharmaceutical partners globally.
Patent CN110592169B reveals a dual-strain microbial method for high-purity ADD production, offering significant cost reduction in pharmaceutical manufacturing and robust supply chain reliability.
Patent CN110656146A reveals an oil-free method for DHEA production using protected phytosterol. This breakthrough offers high purity, reduced waste, and scalable manufacturing for pharmaceutical intermediates.
Patent CN102719496B reveals immobilized yeast catalysis for (S)-(+)-ethyl mandelate. Offers high ee value, mild conditions, and scalable green manufacturing for global supply chains.
Patent CN102363796B details a microbial fermentation method for glycyrrhetinic acid using Aspergillus flavus, offering >98% purity and sustainable supply chain advantages.
Patent CN102719497B details an immobilized yeast method for high-purity methyl (S)-(+)-mandelate. Offers green manufacturing and cost reduction for chiral intermediates.
Patent CN102382785B reveals a novel Morganella morganii strain for high-purity Pregabalin intermediate production, offering significant cost and supply chain advantages.
Novel Mycobacterium neoaurum enables high-yield 9-OH AD production with simplified purification for reliable pharmaceutical intermediate supply chains and cost efficiency.
Patent CN103255191A reveals a high-purity Androstenedione synthesis route. Discover cost-effective biotransformation methods for scalable steroid intermediate production.
Patent CN1954081A reveals advanced biotransformation for colchicinoid derivatives. Achieves higher yields and purity for reliable pharmaceutical intermediate supply chains.
Patent CN102757443A reveals a green biotransformation route for sulfur-substituted podophyllum derivatives, offering cost reduction in API manufacturing and scalable supply chains.
Patent CN102199633B reveals a green yeast-based route for high-purity chiral esters, offering significant cost and supply chain advantages for pharma.
Patent CN102465159B details a green microbial route for Eslicarbazepine. Enhance supply chain reliability and reduce manufacturing costs with this scalable biocatalytic technology.
Patent CN102465159B enables green microbial synthesis. Reduces cost and improves supply chain reliability for epilepsy drug intermediates significantly.
Patent CN101831479B reveals a microbial method for synthesizing sulforaphane precursors, offering significant cost reduction and scalable production for pharmaceutical intermediates.
Patent CN103451242A details a high-yield microbial conversion for 1-alpha-hydroxyvitamin D. Discover cost-effective, scalable manufacturing solutions for active vitamin D intermediates.
Novel Bacillus megaterium strain enables high-purity R-4-chloro-3-hydroxybutyrate production with reduced costs and environmental impact.